Automated Suturing Devices Market Size, Share Outlook, Growth Analysis Report and Forecast Trends 2026-2030

Automated suturing devices encompass powered, mechanical, and robotic-assisted instruments that replace or augment hand-tied stitches, including articulating suture shafts, automated knotting systems, and dedicated robotic suturing tools. The category sits within a broader surgical suture ecosystem that was evaluated at roughly $4 billion in 2021 and is forecast to reach $7 billion by 2030. Clinical adoption is most visible in laparoscopic, colorectal, and minimally invasive cardiac procedures, where consistent stitch quality and reduced operative time are critical.

• •Global automated suturing devices market valued at ~$5.33 billion in 2025.
• •Forecast CAGR of 6.4% places the market on track to surpass $7-8 billion within the decade.
• •Adjacent surgical robotics segment projected to reach $14.3 billion by 2026 at a 10.4% CAGR.

The primary growth catalyst is the rapid uptake of minimally invasive and robotic-assisted surgery, where automated suturing reduces surgeon fatigue and shortens learning curves. Hospital investment in digital OR infrastructure, combined with workforce shortages that incentivize time-saving technologies, is accelerating procurement. Parallel advances in AI-enabled surgical vision and mechatronic actuation are expanding the clinical indications that automated suturing can address.

• •Rising volume of laparoscopic, endoscopic, and robotic procedures globally.
• •Surgeon labor shortages and demand for standardized, reproducible stitch quality.
• •Expansion of healthcare AI, with the segment growing from $26.6 billion in 2024 toward projected multi-hundred-billion levels.

The market segments by product type into automated suturing instruments, disposable loading units, and robotic suturing modules, and by application into general surgery, cardiothoracic, colorectal, gynecological, and urological procedures. North America leads revenue contribution due to early robotic surgery penetration and favorable reimbursement, while Europe shows strong adoption in cardiac surgery using devices such as the RAM annular suturing system. Asia-Pacific is the fastest-growing region, driven by expanding hospital capacity, medical tourism, and harmonizing regulatory frameworks in markets such as India.

• •North America holds the largest revenue share; Asia-Pacific is the fastest-growing regional segment.
• •Disposable cartridges and reloads represent a recurring revenue stream layered on capital equipment sales.
• •Cardiothoracic and colorectal surgery are emerging high-growth application niches.

What are the recent trends and outlook?

The near-term trajectory points toward tighter integration of automated suturing with robotic platforms and AI-driven surgical planning, with engineering prototypes already demonstrating fully autonomous robotic suturing in laboratory settings. Innovation is also moving toward bioengineered and cell-assembled extracellular matrix sutures that could complement mechanical devices in regenerative applications. Regulatory frameworks such as the EU AI Act and India's Medical Devices Rules are pushing manufacturers toward more rigorous clinical evidence, which is expected to favor well-capitalized incumbents while raising the entry bar for startups.

• •Convergence with surgical robotics and AI-based intraoperative guidance is accelerating.
• •Emerging bio-suture and regenerative materials could open adjacent market segments.
• •Tightening device regulation globally favors established manufacturers with strong clinical trial pipelines.